InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
4,604.37
(
0.41%
)
US TECH 100
15,700.80
(
0.54%
)
Dow Jones
36,247.87
(
0.36%
)
Brent Oil
75.97
(
0.00%
)
Bitcoin
43,929.74
(
0.48%
)
Post# of 250025
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 788
Posts 118647
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: dewophile post# 237851

Monday, 11/29/2021 10:11:44 AM

Monday, November 29, 2021 10:11:44 AM

Post# of 250025
BMY—Deucravacitinib for psoriasis has 9/10/22 PDUFA date (with standard FDA review):

https://www.businesswire.com/news/home/20211129005192/en

The Deucra MAA in psoriasis has also been validated by the EMA.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up